Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2004839 citationsMarc Humbert, Richard Beasley et al.Allergyprofile →
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
2001647 citationsM. Solèr, Jonathan Matz et al.European Respiratory Journalprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of H. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Fox more than expected).
This network shows the impact of papers produced by H. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Fox. The network helps show where H. Fox may publish in the future.
Co-authorship network of co-authors of H. Fox
This figure shows the co-authorship network connecting the top 25 collaborators of H. Fox.
A scholar is included among the top collaborators of H. Fox based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H. Fox. H. Fox is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Barton, A.E., I. A. Bertram, G. Borissov, et al.. (2020). Evidence for tt¯ tt¯ production in the multilepton final state in proton–proton collisions at √s=13 TeV with the ATLAS detector:European Physical Journal C.1 indexed citations
Bertram, I. A., et al.. (2013). An improved measurement of direct CP violation parameters in B^+- -> J/psi K^+- and B^+- -> J/psi pi^+- decays.1 indexed citations
4.
Bertram, I. A., et al.. (2013). Measurement of the semileptonic charge asymmetry using Bs^0 -> D_s mu X decays. Lancaster EPrints (Lancaster University).6 indexed citations
Bertram, I. A., G. Borissov, H. Fox, et al.. (2009). Search for NMSSM Higgs bosons in the h->aa->mumu mumu, mumu tautau channels using ppbar collisions at sqrt{s}=1.96 TeV.1 indexed citations
9.
Bertram, I. A., et al.. (2008). Measurement of the ttbar production cross section in ppbar collisions at sqrt{s} = 1.96 TeV. arXiv (Cornell University).
Abazov, V. M., I. A. Bertram, G. Borissov, et al.. (2007). Measurement of the pp‾→tt‾ +X production cross section at √s=1.96 TeV in the fully hadronic decay channel. Oxford University Research Archive (ORA) (University of Oxford). 76(7). 072007-1–072007-11.3 indexed citations
12.
Abazov, V. M., I. A. Bertram, G. Borissov, et al.. (2007). Measurement of the t[overline t] production cross section in p[overline p] collisions at sqrt(s)=1.96 TeV using kinematic characteristics of lepton+jets events. Lancaster EPrints (Lancaster University).7 indexed citations
Humbert, Marc, Richard Beasley, Jon G. Ayres, et al.. (2004). Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 60(3). 309–316.839 indexed citations breakdown →
Solèr, M., Jonathan Matz, Robert G. Townley, et al.. (2001). The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. European Respiratory Journal. 18(2). 254–261.647 indexed citations breakdown →
20.
Abt, I., H. Fox, R.H. Richter, et al.. (1998). Gluing silicon with silicone. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 411(1). 191–196.7 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.